Demystifying the Evergreen myth
This post explores evergreening in pharmaceutical patents and how Section 3d of the Indian Patent Act limits patentability for incremental inventions. It discusses the implications for innovation, generic…
1,294 articles
This post explores evergreening in pharmaceutical patents and how Section 3d of the Indian Patent Act limits patentability for incremental inventions. It discusses the implications for innovation, generic…
This post analyses the public use exemption for patentability through two contrasting US Supreme Court decisions. It highlights how factual circumstances and the presence of experimental use shape…
Section 8 of the Indian Patents Act mandates full disclosure of foreign patent filings by applicants. Failing to comply may result in opposition or patent revocation. This post…
This bulletin presents key updates in Indian patent statistics, including a 50 percent decrease in backlog and recent policy changes. It also covers new IPR educational opportunities, international…
The USPTO has published final rules for administrative trials under the America Invents Act. These rules detail the procedures for inter partes review, post-grant review, and business method…
This post examines the Wankel engine's unique rotary technology, highlighting its development, benefits, and drawbacks. It discusses historical uses, especially by Mazda, and analyses prospects for its future…
This post analyses the development of water walking shoes and related inventions, referencing key international patents and their technological features. The focus is on the evolution from myth…
This post explores Alexander Graham Bell's pioneering work leading to the telephone patent and the disputes with Elisha Gray. It highlights Bell's inventive journey and the lasting impact…
This post examines a patented bicycle pedal extension designed to increase torque and cycling efficiency. It provides a detailed analysis of the invention’s mechanics and its legal significance…
This post discusses the legal grounds for granting compulsory licenses when patented drugs are not locally worked in India, as revealed through recent Form 27 compliance issues. It…